Alemwork Kebede

Selective inhibition of CDK9 in triple negative breast cancer

Zoya Kikhtyak, Benjamin Noll, Van T. M. Nguyen, 2023, Oncogene.

Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutations.

Sunita K. C. Basnet, Aleksandra M Ochnik, Shudong Wang, 2021, European journal of medicinal chemistry.